Enfusion Price Patterns
| ENFNDelisted Stock | USD 10.76 0.00 0.00% |
Momentum
Sell Stretched
Oversold | Overbought |
This module for Enfusion organizes attention data alongside price movement context. The dataset draws on headline frequency data and corresponding price observations.
The hype panel for Enfusion summarizes attention and headline activity. The sentiment data is framed with volatility context for broader interpretation.
Enfusion after-hype prediction price | $ 10.76 |
Sentiment metrics here complement forecasting and technical views with analyst context. The dataset reflects current analytical inputs across multiple dimensions.
Enfusion |
Mean reversion is the tendency of Enfusion's price to return to its historical average after periods of extreme deviation. Some analysts monitor this tendency by comparing Enfusion's price extremes to fundamental value.
After-Hype Price Density Analysis
The price distribution chart for Enfusion visualizes the statistical uncertainty around the model's output. The distribution of Enfusion's predicted prices is derived from Monte Carlo simulations calibrated to Enfusion's realized volatility.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
The downside and upside margins for Enfusion after major news events are estimated from historical precedent. Enfusion's after-hype downside and upside margins for the prediction period are 10.76 and 10.76, respectively. Signal strength depends on the consistency of Enfusion's past reactions to comparable news categories.
Current Value
The next after-hype price estimate for Enfusion is modeled on a 3 months horizon and is intended to show how price could normalize after sentiment pressure fades. Enfusion is Very Low at this time.
Price Outlook Analysis
If Enfusion's price is climbing without matching news, momentum forces may be at play. Volume spikes in Enfusion without matching news often signal that momentum is driving the trades. Checking Enfusion's trading volume along with price action helps tell real demand from speculative froth. The mix of hype and core data in Enfusion creates both risks and chances for alert traders.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 3 Events | 5 Events | In 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
10.76 | 10.76 | 0.00 |
|
Hype Timeline
Enfusion is currently traded for 10.76. The company stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Enfusion is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Enfusion is about 0.0%, with the expected price after the next announcement by competition of 10.76. About 96.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.35. Enfusion had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in 3 days. Enfusion has a market cap of 1.02 B, operating margin of 2.99%, current ratio of 9.17. See Investing Opportunities for portfolio-level analysis. Broader economic conditions can influence Enfusion's company valuation — related indicators include signals in price.Related Hype Analysis
The relationship between Enfusion and its sector peers means news affecting one company often reverberates across Enfusion's landscape. Whether the news affects the sector broadly or competitively determines if Enfusion's shares move in sympathy or contrast.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ETWO | E2open Parent Holdings | -0.32 | 9 per month | 1.06 | 0.19 | 4.93 | -3.02 | 26.87 | |
| ML | MoneyLion | -0.32 | 3 per month | 0.57 | 0.12 | 0.68 | -0.86 | 2.27 | |
| VERB | Verb Technology | -0.32 | 18 per month | 4.79 | 0.07 | 9.95 | -8.10 | 38.35 | |
| CLBT | Cellebrite DI | 0.41 | 7 per month | 0.00 | -0.07 | 5.78 | -4.50 | 16.13 | |
| MODN | Model N | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AVPT | Avepoint | 0.09 | 8 per month | 0.00 | -0.15 | 2.93 | -3.87 | 12.57 | |
| WKME | Walkme | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PENG | Penguin Solutions | -0.32 | 10 per month | 0.00 | -0.01 | 3.92 | -3.84 | 17.68 | |
| MKFG | Markforged Holding Corp | 0.00 | 7 per month | 3.98 | 0.13 | 9.46 | -5.78 | 33.63 |
Enfusion Additional Predictive Modules
Enfusion predictive analysis applies quantitative techniques to historical price data, aiming to identify conditions that have preceded similar moves in the past. No prediction model eliminates uncertainty; the goal is to identify scenarios with favorable risk-adjusted probabilities.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sentiment Indicators & Methodology
Sentiment analysis for Enfusion evaluates news tone, positioning, and narrative momentum. Positioning shifts can amplify volatility changes during regime transitions. Enfusion has a market cap of 1.02 B, P/E of 0.11, ROE of 4.42%.
This section for Enfusion is built from periodic company reporting and market reference feeds, with reporting definitions aligned before display. Values may update on different source schedules.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardPair Trading with Enfusion
Pair trading with Enfusion can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. This framework is most useful when investors want to hedge directional moves caused by sector headlines or broad market pressure.
Moving against Enfusion Stock
| 0.65 | ELGL | Element Global | PairCorr |
| 0.37 | VZ | Verizon Communications | PairCorr |
| 0.33 | CVX | Chevron Corp | PairCorr |
| 0.32 | TRV | The Travelers Companies | PairCorr |
Identifying assets closely correlated with Enfusion is essential for tax-loss harvesting strategies. The wash-sale rule prohibits repurchasing Enfusion within 30 days of a loss sale.
The correlation coefficient for Enfusion quantifies co-movement strength on a scale from -1 to +1. Holding two assets with correlation close to +1 alongside Enfusion offers minimal diversification value.
Use Correlation analysis and pair trading evaluation for Enfusion to review hedging context.Enfusion has a market cap of 1.02 B, operating margin of 2.99%, current ratio of 9.17. See Investing Opportunities for portfolio-level analysis. Broader economic conditions can influence Enfusion's company valuation — related indicators include signals in price. With Enfusion showing P/E 0.11 and ROE 4.42%, investors get more value when this analysis is combined with the diversification and construction tools below. Within the Technology space, these metrics give the peer comparison tools below a concrete starting point for relative analysis. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Enfusion Stock
Delisted instruments like Enfusion often face wider spreads and reduced transparency.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash position to determine if your portfolio needs rebalancing | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Prophet Use AI to generate optimal portfolios and find investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |